Skip to main content
Year archive

Mabpharm Limited — 2022 filings

All 30 regulatory filings released by Mabpharm Limited (2181) in 2022, sourced directly from the official regulator.

30 Filings
2022 Period
2022 filings (30)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-05 English
2022 Interim Report
Regulatory Filings
2022-09-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
Regulatory Filings
2022-08-26 English
DATE OF BOARD MEETING
Regulatory Filings
2022-08-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-02 English
VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF CMAB015 BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
Regulatory Filings
2022-07-27 English
VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF BIOLOGICAL CLASS I NEW DRUG CMAB017 BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
Regulatory Filings
2022-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-04 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 17, 2022
Regulatory Filings
2022-06-21 English
SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2022-06-17 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2022-06-17 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 17 JUNE 2022
Regulatory Filings
2022-06-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-06 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 17, 2022
Regulatory Filings
2022-04-21 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-21 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF
Regulatory Filings
2022-04-21 English
2021 Annual Report
Regulatory Filings
2022-04-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-06 English
VOLUNTARY ANNOUNCEMENT EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH KEXING BIOPHARM REGARDING CMAB008 (INFLIXIMAB) IN MAINLAND CHINA
Regulatory Filings
2022-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
Regulatory Filings
2022-03-25 English
PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2022-03-25 English
DATE OF BOARD MEETING
Regulatory Filings
2022-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION OF CMAB807X BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
Regulatory Filings
2022-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-05 English